News Conference News CX Symposium 2025 Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices L.A. McKeown April 23, 2025
News Conference News VIVA 2024 Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II L.A. McKeown November 06, 2024
News Conference News ESC 2024 New ESC Guidelines Merge PAD, Aortic Diseases Into Single Document Caitlin E. Cox September 10, 2024
News Conference News LINC 2023 What Works, What’s Noise? Novel Approaches Offer Hope in CLTI L.A. McKeown June 07, 2023
News Conference News VIVA 2021 Diverting or Swirling, New Blood-Flow Tech Shows Promise for CLTI L.A. McKeown October 08, 2021
News Conference News VIVA 2019 Calcium Conundrum: New Scores, Research Aim to Boost Outcomes in PAD Interventions L.A. McKeown November 13, 2019
News Conference News ISET 2018 Noninvasive Testing of CLI: Many Ways to Draw Up a ‘Roadmap’ Caitlin E. Cox February 05, 2018
News Conference News VIVA 2017 DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease L.A. McKeown September 13, 2017
News Conference News VIVA 2017 Apixaban May Be Better Choice Than Rivaroxaban for DVT Patients L.A. McKeown September 11, 2017
News Conference News ISET 2017 Underappreciated by Clinicians, Critical Limb Ischemia Has Dire Fallout for Patients Caitlin E. Cox February 07, 2017
News Conference News EuroPCR 2013 Paclitaxel Delivery Key to PAD Intervention Caitlin E. Cox May 22, 2013
News Conference News AHA 2012 OLIVE: Endovascular Treatment Shows Positive Results for Critical Limb Ischemia Jason Kahn November 06, 2012